跳至主要内容
临床试验/ITMCTR2000002946
ITMCTR2000002946招募中1 期

Chinese Herbal medicine for Severe nevel coronavirus pneumonia (COVID-19): a Randomized Controlled Trial

Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 —(—)
性别
All

入选标准

  • 1) Aged >= 18 years;
  • 2) Meet the diagnostic criteria of severe pneumonia patients with new coronavirus;
  • 3) The informed consent form.

排除标准

  • 1) Severe basic diseases that affect survival, including: uncontrolled malignant tumors with multiple metastases that cannot be removed, hematological diseases, cachexia, active bleeding, severe malnutrition, HIV, etc.;
  • 2) Obstructive pneumonia caused by lung tumors, severe pulmonary interstitial fibrosis, alveolar proteinosis, allergic reaction alveolitis;
  • 3) Previous immunosuppressive agents within 6 months before study entry or recipients of a solid-organ or bone marrow transplant;
  • 4) Pregnant or lactating women;
  • 5) Researchers believe that patients may have other factors affecting the efficacy or safety evaluation of this study.

研究者

发起方
Dongzhimen Hospital Affiliated to Beijing University of Chinese Medicine

相似试验